[go: up one dir, main page]

NO20022663L - Substituted phthalocyanines and their precursors - Google Patents

Substituted phthalocyanines and their precursors

Info

Publication number
NO20022663L
NO20022663L NO20022663A NO20022663A NO20022663L NO 20022663 L NO20022663 L NO 20022663L NO 20022663 A NO20022663 A NO 20022663A NO 20022663 A NO20022663 A NO 20022663A NO 20022663 L NO20022663 L NO 20022663L
Authority
NO
Norway
Prior art keywords
substituted
phthalonitrile
phthalocyanines
substituted phthalocyanines
precursors
Prior art date
Application number
NO20022663A
Other languages
Norwegian (no)
Other versions
NO20022663D0 (en
Inventor
Michael John Cook
Martin James Heeney
Original Assignee
Gentian As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9929064.5A external-priority patent/GB9929064D0/en
Priority claimed from GBGB0025817.8A external-priority patent/GB0025817D0/en
Application filed by Gentian As filed Critical Gentian As
Publication of NO20022663D0 publication Critical patent/NO20022663D0/en
Publication of NO20022663L publication Critical patent/NO20022663L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0076—PDT with expanded (metallo)porphyrins, i.e. having more than 20 ring atoms, e.g. texaphyrins, sapphyrins, hexaphyrins, pentaphyrins, porphocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y10/00—Nanotechnology for information processing, storage or transmission, e.g. quantum computing or single electron logic
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B47/00—Porphines; Azaporphines
    • C09B47/04—Phthalocyanines abbreviation: Pc
    • C09B47/045—Special non-pigmentary uses, e.g. catalyst, photosensitisers of phthalocyanine dyes or pigments
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B47/00—Porphines; Azaporphines
    • C09B47/04—Phthalocyanines abbreviation: Pc
    • C09B47/06—Preparation from carboxylic acids or derivatives thereof, e.g. anhydrides, amides, mononitriles, phthalimide, o-cyanobenzamide
    • C09B47/067—Preparation from carboxylic acids or derivatives thereof, e.g. anhydrides, amides, mononitriles, phthalimide, o-cyanobenzamide from phthalodinitriles naphthalenedinitriles, aromatic dinitriles prepared in situ, hydrogenated phthalodinitrile
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B47/00—Porphines; Azaporphines
    • C09B47/04—Phthalocyanines abbreviation: Pc
    • C09B47/06—Preparation from carboxylic acids or derivatives thereof, e.g. anhydrides, amides, mononitriles, phthalimide, o-cyanobenzamide
    • C09B47/067—Preparation from carboxylic acids or derivatives thereof, e.g. anhydrides, amides, mononitriles, phthalimide, o-cyanobenzamide from phthalodinitriles naphthalenedinitriles, aromatic dinitriles prepared in situ, hydrogenated phthalodinitrile
    • C09B47/0673—Preparation from carboxylic acids or derivatives thereof, e.g. anhydrides, amides, mononitriles, phthalimide, o-cyanobenzamide from phthalodinitriles naphthalenedinitriles, aromatic dinitriles prepared in situ, hydrogenated phthalodinitrile having alkyl radicals linked directly to the Pc skeleton; having carbocyclic groups linked directly to the skeleton

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Nanotechnology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Theoretical Computer Science (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Mathematical Physics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Virology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Oppfinnelsen vedrører en fremgangsmåte for fremstilling av ftalonitrilsulfonatestere, en fremgangsmåte for fremstilling av substituerte ftalonitriler ved anvendelse av de nevnte ftalonitrilsulfonatestere, en fremgangsmåte for fremstilling av substituerte ftalocyaniner ved anvendelse av de nevnte substituerte ftalonitriler, en fremgangsmåte for fremstilling av ftalonitrilhalogenider, en fremgangsmåte for fremstilling av substituerte ftalocyaniner ved anvendelse av de nevnte ftalonitrilhalogenider, nye ftalonitrilsulfonatestere, nye substituerte ftalonitriler, nye substituerte ftalocyaniner og visse anvendelser av de nevnte nye substituerte ftalo- cyaniner.The invention relates to a process for the preparation of phthalonitrile sulfonate esters, a process for the preparation of substituted phthalonitriles using said phthalonitrile sulfonate esters, a process for the production of substituted phthalocyanines using said substituted phthalonitrile preparation, a process for said phthalonitrile substituted phthalocyanines using the said phthalonitrile halides, new phthalonitrile sulfonate esters, new substituted phthalonitriles, new substituted phthalocyanines, and certain uses of said new substituted phthalocyanines.

NO20022663A 1999-12-08 2002-06-05 Substituted phthalocyanines and their precursors NO20022663L (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9929064.5A GB9929064D0 (en) 1999-12-08 1999-12-08 Substituted phthalocyanines and their precursors
GB0012348A GB0012348D0 (en) 1999-12-08 2000-05-22 Substituted phthalocyanines and their precursors
GBGB0025817.8A GB0025817D0 (en) 1999-12-08 2000-10-20 Substituted phthalocyanines and their precursors
PCT/GB2000/004708 WO2001042368A1 (en) 1999-12-08 2000-12-08 Substituted phthalocyanines and their precursors

Publications (2)

Publication Number Publication Date
NO20022663D0 NO20022663D0 (en) 2002-06-05
NO20022663L true NO20022663L (en) 2002-08-08

Family

ID=27255732

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20022663A NO20022663L (en) 1999-12-08 2002-06-05 Substituted phthalocyanines and their precursors

Country Status (10)

Country Link
EP (1) EP1238016A1 (en)
JP (1) JP2003516421A (en)
AU (1) AU2192201A (en)
CA (1) CA2394891A1 (en)
CZ (1) CZ20021974A3 (en)
EE (1) EE200200298A (en)
HU (1) HUP0301099A3 (en)
NO (1) NO20022663L (en)
PL (1) PL355851A1 (en)
WO (1) WO2001042368A1 (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002341034B2 (en) * 2001-03-21 2007-06-14 Molteni Therapeutics S.R.L. Metal substituted non centrosimmetrical phthalocyanine analogues, their preparation and use in photodynamic therapy and in vivo diagnostic
US7091373B2 (en) 2002-03-18 2006-08-15 Sumitomo Chemical Company, Limited Production method for biarylalanine
CN100415715C (en) * 2003-02-11 2008-09-03 杜锡光 Superphthalocyanine compound with six isoindole structural subunits in porphyrazine ring, synthesis method and application
CA2525447C (en) * 2003-05-14 2013-08-06 Universite De Sherbrooke Amphiphilic trisulfonated porphyrazines for photodynamic applications in medicine
JP4809657B2 (en) * 2005-09-29 2011-11-09 富士フイルム株式会社 Naphthalocyanine dye and method for producing the same
JP4942351B2 (en) * 2006-01-31 2012-05-30 独立行政法人科学技術振興機構 Photodynamic therapy anticancer agent
JP5296355B2 (en) * 2007-09-11 2013-09-25 株式会社日本触媒 Aryl group-containing phthalocyanine compound, method for producing the same, and compound
US8168359B2 (en) * 2008-03-10 2012-05-01 Xerox Corporation Nanosized particles of phthalocyanine pigments
CZ303612B6 (en) * 2010-08-19 2013-01-09 Výzkumný ústav organických syntéz a.s. Compound based on phthalocyanine derivative for photodynamic inactivation of both gram-positive and gram-negative bacteria as well as pathogenic yeast, and use of this compound
JP2012167189A (en) * 2011-02-14 2012-09-06 Aisin Seiki Co Ltd Phthalocyanine derivative, method for producing the same, and dye-sensitized solar cell
JP2013193956A (en) * 2012-03-15 2013-09-30 Saitama Univ Tetrakis-trialkyl or phenylsilylethynyl-substituted phthalocyanine, and method for producing the same
JP6278386B2 (en) * 2013-11-06 2018-02-14 国立研究開発法人産業技術総合研究所 Phthalocyanine compounds and organic semiconductor materials
CN103864645B (en) * 2013-12-30 2016-08-17 常州大学 A kind of two replacement perfluoroalkyl phthalonitrile compound and preparation method thereof
CN104016995A (en) * 2014-06-26 2014-09-03 常州大学 Octa-substituted perfluoroalkyl cobalt phthalocyanine compound and preparation method thereof
JP6608187B2 (en) * 2015-06-22 2019-11-20 山本化成株式会社 Sensitizing dye, semiconductor electrode, photoelectric conversion element, and dye-sensitized solar cell
TWI705061B (en) 2016-08-24 2020-09-21 德商賽諾拉公司 Organic molecules, especially for use in organic optoelectronic devices
CN108017650A (en) * 2017-03-08 2018-05-11 先尼科化工（上海）有限公司 A kind of phthalocyanine compound for optical filter and its preparation method and application method
CN110494501B (en) * 2017-04-07 2022-04-19 山本化成株式会社 Phthalocyanine-based compound and use thereof
EP3611175B1 (en) * 2017-04-07 2022-02-09 Yamamoto Chemicals, Inc. Naphthalocyanine compound, method for producing same, and use thereof
JP6922361B2 (en) * 2017-04-07 2021-08-18 Jsr株式会社 Composition for solid-state image sensor, infrared shielding film and solid-state image sensor
WO2020071470A1 (en) * 2018-10-05 2020-04-09 山本化成株式会社 Phthalocyanine compound and use thereof
CN112279856B (en) * 2019-07-24 2021-09-17 南方科技大学 Non-peripherally-substituted soluble metal phthalocyanine, synthesis method and application thereof, and perovskite solar cell
CN112014383B (en) * 2020-06-30 2024-03-29 杜旭忠 Photosensitizer for homogeneous chemiluminescence and preparation method and application thereof
KR20230044432A (en) * 2020-07-31 2023-04-04 스미또모 가가꾸 가부시키가이샤 compound
CN112812299B (en) * 2020-12-31 2022-03-29 四川大学 Phthalonitrile and amino acid cyclic peptide copolymer resin and preparation method thereof
JPWO2022196089A1 (en) * 2021-03-15 2022-09-22
EP4574911A1 (en) 2023-12-22 2025-06-25 Holland Colours N. V. Bio-sourced phthalocyanine complex, preparation and use thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0155780B1 (en) * 1984-03-21 1990-03-28 Imperial Chemical Industries Plc Infra-red absorber
GB8431446D0 (en) * 1984-12-13 1985-01-23 Secr Defence Alkoxyphthalocyanines
GB8619238D0 (en) * 1986-08-06 1986-09-17 Ici Plc Organic photoconductor
JP2613647B2 (en) * 1987-02-13 1997-05-28 イギリス国 Substituted phthalocyanines
JPH0730300B2 (en) * 1988-04-01 1995-04-05 三井東圧化学株式会社 Alkyl phthalocyanine near infrared absorber and display / recording material using the same
CA2005520A1 (en) * 1988-12-15 1990-06-15 Hisato Itoh Near infrared absorbent and display/recording materials prepared by using same
JPH07103093B2 (en) * 1989-01-12 1995-11-08 三井東圧化学株式会社 Phthalonitrile-based compound and method for producing the same
DE69228502T2 (en) * 1991-06-19 1999-08-12 Mitsui Chemicals, Inc., Tokio/Tokyo Phthalocyanine compounds and their use
ATE174942T1 (en) * 1991-11-08 1999-01-15 Eastman Chem Co THERMOPLASTIC POLYMER COMPOSITION CONTAINING ONE OR MORE MONOMERIC NEAR INFAROT FLUORESCENT COMPOUNDS MIXED THEREIN
GB9317881D0 (en) * 1993-08-27 1993-10-13 Secr Defence Photosensitizers
US5456998A (en) * 1994-04-26 1995-10-10 Xerox Corporation Photoconductive imaging members containing alkoxy-bridged metallophthalocyanine dimers
JPH0892190A (en) * 1994-09-26 1996-04-09 Kanto Chem Co Inc Cyanobiphenyl derivative and liquid crystal composition containing the derivative
GB9613476D0 (en) * 1996-06-27 1996-08-28 British Polythene Ltd Improvements in or relating to films and/or coatings
IT1294325B1 (en) * 1997-08-14 1999-03-24 Molteni L E C Dei Fratelli Ali ZINC-PHTHALOCYANINS AND THEIR CONJUGATES, PREPARATION AND USE IN PHOTODYNAMIC THERAPY AND AS DIAGNOSTIC
US6511971B1 (en) * 1998-10-13 2003-01-28 Brown University Research Foundation Substituted perhalogenated phthalocyanines

Also Published As

Publication number Publication date
HUP0301099A3 (en) 2003-11-28
EP1238016A1 (en) 2002-09-11
NO20022663D0 (en) 2002-06-05
WO2001042368A1 (en) 2001-06-14
EE200200298A (en) 2003-08-15
AU2192201A (en) 2001-06-18
CZ20021974A3 (en) 2002-11-13
CA2394891A1 (en) 2001-06-14
JP2003516421A (en) 2003-05-13
HUP0301099A2 (en) 2003-08-28
PL355851A1 (en) 2004-05-31

Similar Documents

Publication Publication Date Title
NO20022663L (en) Substituted phthalocyanines and their precursors
AU2002341989A1 (en) Process to produce derivatives from uk-2a derivatives
MXPA03011329A (en) Novel anti-infectives.
AU2001288066A1 (en) Process for production of aromatic polycarbonates
AU2002352353A1 (en) Process for production of styrene
AU2002333347A1 (en) Process for the production of scleroglucan
AU1342001A (en) Enhancement of production of camptothecins from plants
IL158998A0 (en) Process for the production of 4-amino-2, 5-bisheterocyclylquinazolines
PT1307436E (en) PROCESS FOR THE PREPARATION OF BACATINE DERIVATIVES III
WO2002046152A3 (en) Coniosetin and derivatives thereof, method for producing the same and use thereof
WO2000064882A3 (en) Enantiomers of mercapto lactones and processes for their synthesis
NO20020308D0 (en) Process for the preparation of epothiolone B and derivatives, as well as intermediates for the process
AU2001292236A1 (en) 5-phenylbenzylamine compounds, process for their production and intermediates for their synthesis
AU2002335992A1 (en) Process for the production of ascopyrone p
AU2002216102A1 (en) Method for producing biomass
YU67203A (en) Caloporoside-derivatives, methods for the production thereof and their use
NO20041537L (en) Process for the preparation of 14beta-hydroxy-baccatin III-1,14-carbonate
AU5219700A (en) Halopyrimidines
AU2003235376A1 (en) Process for the manufacturing of cellulose pulp
AU5925498A (en) Processes for producing 3-cyanopyridine from 2-methyl-1,5-pentanediamine
AU2002301062A1 (en) Novel pulping method to improve the quality of recycled fibers
EG23198A (en) Process for production of alcohol derivatives.
WO2004076388A3 (en) Process for preparing 2-methylpyrrolidine and specific enantiomers thereof
AU2002318668A1 (en) Process for producing benzofuran derivative
AU2002232297A1 (en) Process to produce paroxetine

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application